Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Gilead Sciences, Inc. GILD NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
78/100
6/7 Pass
SharesGrow Intrinsic Value
$262.18
+86.7%
Analyst Price Target
$158.71
+13%
Metric TTM (2025-03 – 2025-12)
Revenue $29.44B
Gross Profit $23.79B
Gross Margin 80.8%
Operating Income $11B
Net Income $8.51B
Net Margin 28.9%
EPS (Diluted) $6.77

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
 AMGN
AMGN
Amgen Inc.
$350.95
+0.32%
 PFE
PFE
Pfizer Inc.
$27.13
-0.77%
 BMY
BMY
Bristol-Myers Squibb Company
$58.08
+0.03%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message